Meet the Cell Shuttle

A factory-in-a-box for industrial scale cell therapy manufacturing.

Cellares’ Cell Shuttle

“Cellares’ revolutionary technology will be a game changer for the cell therapy industry!”

Carl June, MD

Professor in Immunotherapy

University of Pennsylvania

Cellares Advisory Board Member

It’s Time to Automate

The potential of cell therapy is proven, but its impact is limited by manufacturing bottlenecks. Currently, there is no scalable manufacturing solution for cell therapies and existing processes are disjointed, cost prohibitive, failure prone and unable to meet market demand.

$11.6B

Cell Therapy Manufacturing Market by 2030

Source: Roots Analysis

600+

Clinical Trials Underway

Source: Alliance for Regenerative Medicine

5%-10%

Of the Required Manufacturing Capacity Exists Today

Source: Kineticos Life Sciences

Taking on the Challenge

Cellares revolutionary technology is robust, cost-effective and will enable the parallel production of thousands of cell therapy doses per month. We’re saving lives by delivering safe and affordable access to novel cell therapies for patients in need.

  •  
    Automated
  •  
    Flexible
  •  
    Scalable
  •  
    Robust
  •  
    Cost-efficient
Select the icons above to learn more
True walk-away, end-to-end automation–from starting material to fill and finish.
Modular hardware supports the vast majority of cell therapy applications, including CAR-T, TCR, NK and HSC based worklflows. A purpose-built process design software puts the power to define manufacturing workflows at your fingertips.
The first manufacturing platform that scales from high-throughput preclinical work to commercial scale, empowering you to meet market demand for your drug.
Three-fold reduction in process failure rates through elimination of operator error and contamination during open transfer steps.
Up to 70% cost reduction compared to open and manual manufacturing processes.

Automated

True walk-away, end-to-end automation from loading the starting material to unloading a cell therapy product ready for administration.

Flexible

Modular hardware supports the vast majority of cell therapy applications, including CAR-T, TCR, NK and HSC based workflows. A purpose-built process design software puts the power to define manufacturing workflows at your fingertips.

Scalable

The first manufacturing platform that scales from high-throughput preclinical work to commercial scale, empowering you to meet market demand for your drug.

Robust

Three-fold reduction in process failure rates through elimination of operator error and contamination during open transfer steps.

Cost-efficient

Up to 70% cost reduction compared to open and manual manufacturing processes.

Slider

Join our Team

We are always looking for creative and passionate people to join our interdisciplinary team.

 

Recent News

Fierce Pharma

Fierce Pharma

May 6th, 2021 – Cellares raises $82M to drive work on cell therapy ‘factory-in-a-box’

Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy

Second industry partner to enter a strategic relationship with Cellares...

Fierce Pharma

May 6th, 2021 - Cellares raises $82M to drive work on cell therapy 'factory-in-a-box'

Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing

May 5th, 2021 - Cellares Corporation, a life sciences technology company that automates cell...

Slider